FACE Related Analyst Ratings
-
Citi Downgrades Physicians Formula (FACE) to Hold; Loss Reduces Visibility Significantly
-
Piper Jaffray Downgrades Physicians Formula (FACE) to Neutral
-
Citi Maintains 'Buy' Rating on Physicians Formula (FACE), Lowers PT and 2008-09 Estimates
-
Piper Jaffray Maintains 'Buy' Rating on Physicians Formula Holdings (FACE), But Lowers PT and Estimates
-
Citi's Analysts Announce Favorite Strategy Stocks After Small/Mid Cap Conference
-
Piper Jaffray Reiterates Buy on Physicians Formula (FACE); $16 PT
-
Citi Upgrades Physicians Formula Holdings (FACE) to Buy
-
Piper Jaffray Lowers Their Price Target on Physicians Formula (FACE) to $15
-
Wachovia Downgrades Physicians Formula Holdings (FACE) to Market Perform
-
Piper Jaffray Defends Physicians Formula (FACE) Following Warning
-
Wachovia Starts Physicians Formula Holdings (FACE) at Outperform
-
Piper Jaffray Starts Physicians Formula (FACE) at Outperform
-
Citigroup Initiates Coverage on Physicians Formula Holdings (FACE) with a Hold
-
Deutsche Bank Starts Physicians Formula (FACE) at Buy
Back to FACE Stock Lookup
